Cranial and peripheral interictal vascular changes in migraine patients

Cephalalgia

Volumn 23, Issue 2, 2003, Pages 96-104

  De Hoon, Jan ^a,b   Willigers, J M ^c   Troost, J ^d   Struijker Boudier, H A ^b   Van Bortel, L M ^b,e  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e GHENT UNIVERSITY   (Belgium)

Author keywords

Interictal arterial wall properties; Migraine; Vascular properties

Indexed keywords

ADULT; ARTERY DIAMETER; ARTICLE; BRACHIAL ARTERY; CAROTID ARTERY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HEART OUTPUT; HUMAN; MALE; MIGRAINE; SYSTEMIC VASCULAR RESISTANCE; TEMPORAL ARTERY; TONOMETRY; VASOSPASM;

ADULT; BLOOD PRESSURE; BRACHIAL ARTERY; BRAIN; CARDIAC OUTPUT; CAROTID ARTERY, COMMON; CEREBROVASCULAR CIRCULATION; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NORWAY; TEMPORAL ARTERIES; VASCULAR RESISTANCE;

EID: 0037346861     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2003.00465.x     Document Type: Article

References (48)

1. Graham JR, Wolff HG. Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psych 1938; 39:737-63.
2. Goadsby PJ, Lipton RB, Ferrari MD. Migraine, current understanding and treatment. N Engl J Med 2002; 346:257-70.
3. Friberg L. Cerebral blood flow changes in migraine: methods, observations and hypotheses. J Neurol 1991; 238:S12-S17.
4. Olesen J. Cerebral and extracranial circulatory disturbances in migraine: pathophysiological implications. Cerebrovasc Brain Metab Rev 1991; 3:1-28.
5. Iversen HK, Nielsen TH, Olesen J, Tfelt-Hansen P. Arterial responses during migraine headache. Lancet 1990; 336:837-9.
6. Drummond PD, Lance JW. Extracranial vascular changes and the source of pain in migraine headache. Ann Neurol 1983; 13:32-7.
7. Lafitte C, Even C, Henry-Lebras F et al. Migraine and angina pectoris by coronary artery spasm. Headache 1996; 36:332-4.
8. Heupler FA. Syndrome of symptomatic coronary arterial spasm with nearly normal coronary arteriograms. Am J Cardiol 1980; 45:873-81.
9. Miller D, Waters DD, Warnica W et al. Is variant angina the coronary manifestation of a generalized vasospastic disorder? N Engl J Med 1981; 304:763-6.
10. Zahavi I, Chagnac A, Hering R et al. Prevalence of Raynaud's phenomenon in patients with migraine. Arch Intern Med 1984; 144:742-4.
11. Carolei A, Marini C, De Matteis G. History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. Lancet 1996; 347:1503-6.
12. Merikangas KR, Fenton BT, Cheng SH et al. Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol 1997; 54:362-8.
13. Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Br Med J 1999; 318:13-8.
14. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8:1-96.
15. Kelly R, Hayward C, Ganis J et al. Noninvasive registration of the arterial pressure pulse waveform using high-fidelity applanation tonometry. J Vasc Med Biol 1989; 1:142-9.
16. de Hoon JNJM, Hoeks APG, Willigers JM, Van Bortel LMAB. Non-invasive assessment of pulse pressure at different peripheral arteries in man. Neth J Med 1998; 52:A36.
17. O'Rourke MF, Pauca A, Jiang X-J. Pulse wave analysis. Br J Clin Pharmacol 2001; 51:507-22.
18. Hoeks APG, Brands PJ, Smeets FAM, Reneman RS. Assessment of the distensibility of superficial arteries. Ultrasound Med Biol 1990; 16:121-8.
19. Kool MJF, van Merode T, Reneman RS et al. Evaluation and reproducibility of a vessel wall movement detector system for assessment of large artery properties. Cardiovasc Res 1994; 28:610-4.
20. Willekes C, Hoeks APG, Bots ML et al. Evaluation of off-line automated intima-media thickness detection of the common carotid artery based on M-line signal processing. Ultrasound Med Biol 1999; 25:57-64.
21. Huntsman LL, Stewart DK, Barnes SR et al. Noninvasive doppler determination of cardiac output in man. Circulation 1983; 67:593-602.
22. Blau JN. Migraine: a vasomotor instability of the meningeal circulation. Lancet 1978; ii:1136-9.
23. Thomsen LL, Olesen J. The autonomic nervous system and the regulation of arterial tone in migraine. Clin Auton Res 1995; 5:243-50.
24. Laurent S, Caviezel B, Beck L et al. Carotid artery distensibility and distending pressure in hypertensive humans. Hypertension 1994; 23:878-83.
25. Barenbrock M, Spieker C, Witta J et al. Reduced distensibility of the common carotid artery in patients treated with ergotamine. Hypertension 1996; 28:115-9.
26. O'Rourke MF. Arterial function in health and disease. Edinburgh: Chirchill Livingstone, 1992.
27. Safar ME, Levy BI, Laurent S, London GM. Hypertension and the arterial system: clinical and therapeutic aspects. J Hypertens 1990; 5:S113-S119.
28. Cortelli P, Pierangeli G, Parchi P et al. Autonomic nervous system function in migraine without aura. Headache 1991; 31:457-62.
29. Martin R, Ribera C, Molto JM et al. Cardiovascular reflexes in patients with vascular headache. Cephalalgia 1992; 12:360-4.
30. Raskin NHH. Serotonin receptors and headache. N Engl J Med 1991; 325:353-4.
31. Ferrari MD, Saxena PF. On serotonin and migraine: a clinical and pharmacological review. Cephalalgia 1993; 13:151-6.
32. Blauw GJ, Van Brummelen P, Chang PC, Van Zwieten PA. Regional vascular effects of serotonin and ketanserin in young healthy subjects. Hypertension 1988; 11:256-63.
33. Cohen RA. Adenosine nucleotides and 5-hydroxytryptamine released by aggregating platelets inhibit adrenergic neurotransmission in canine coronary artery. J Clin Invest 1986; 77:369-75.
34. Joannides R, Richard V, Haefeli WE et al. Role of basal and stimulated release of nitric oxide in the regulation of radial artery caliber in humans. Hypertension 1995; 26:327-31.
35. Gallai V, Floridi A, Mazotta G et al. L-arginine/nitric oxide pathway activation in platelets of migraine patients with and without aura. Acta Neurol Scand 1996; 94:151-60.
36. Olesen J, Thomsen LL, Iversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci 1994; 15:149-53.
37. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2:997-1000.
38. Tzourio C, El Amrani M, Ladislas R, Alperovitch A. Serum elastase activity is elevated in migraine. Ann Neurol 2000; 47:648-51.
39. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990; 28:183-7.
40. Portaluppi F, Vergnani L, Margutti A, Ambrosia MR, Bondanelli M, Transforini G et al. Modulatory effect of the renin-angiotensin system on the plasma levels of CGRP in normal man. J Clin Endocrinol Metab 1993; 77:816-20.
41. Fiscus RR. CGRP inhibits proliferation of cultured bovine aortic smooth muscle cells - potential anti-atherogenic action of CGRP. FASEB 1993; 7:791.
42. Ashina M, Bendtsen L, Jensen R, Schifter S, Olesen J. Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks. Pain 2000; 86:133-8.
43. de Hoon JNJM, Willigers JM, Troost J et al. Vascular effects of 5-HT1B/1D-receptor agonists in patients with migraine headaches. Clin Pharmacol Ther 2000; 68:418-26.
44. de Hoon JNJM, Poppe KA, Thijssen HHW et al. Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data. Br J Clin Pharmacol 2001; 52:45-51.
45. Tfelt-Hansen P, Paalzow L. Intramuscular ergotamine: plasma levels and dynamic activity. Clin Pharmacol Ther 1985; 37:29-35.
46. Schrader H, Stovner LJ, Helde G et al. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. Br Med J 2001; 322:19-29.
47. Van Bortel LMAB, Kool MJF, Struijker-Boudier HAJ. Effects of antihypertensive agents on local arterial distensibility and compliance. Hypertension 1995; 26:531-4.
48. Safar ME, Van Bortel LMAB, Struijker-Boudier HAJ. Resistance and conduit arteries following converting enzyme inhibition in hypertension. J Vasc Res 1997; 34:67-81.